They reported that rapamycin-induced mTOR inhibition significantly decreased splenomegaly through the inhibition of lymphocyte proliferation, angiogenesis, fibrogenesis and tissue inflammation levels, which ultimately led to a decrease in portal pressure [25]. This evidence concerns the gene MTOR and Splenomegaly.